other material
confidence high
sentiment neutral
materiality 0.55
Citius Pharma raises $2M in registered direct offering; proceeds for LYMPHIR launch
Citius Pharmaceuticals, Inc.
- Offering of 465,000 shares at $1.15 and 1,274,131 pre-funded warrants at $1.1499.
- Net proceeds ~$1.735M after fees; used for commercial launch of LYMPHIR and general corporate purposes.
- Placement agent H.C. Wainwright received 7% cash fee and 121,739 warrants exercisable at $1.4375.
- Company agreed to 30-day lock-up on further equity issuances.